Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Illinois at Chicago

About this trial

Fight Fatigue is evaluating the feasibility and acceptability of a combined progressive muscle relaxation and walking intervention to reduce fatigue for adults with end-stage kidney disease receiving in-center hemodialysis.

Eligibility criteria

Qualifiers

Diagnosis of ESKD diagnosis and receiving hemodialysis for at least 3 months

Can read and speak English

Fatigue measured via visual analogue scale, score ≥4 over the last week

Able to stand and walk one block

Disqualifiers

Patient's nephrologist refuses for them to participate

Unstable angina

Unstable pulmonary disease or pulmonary symptoms that preclude participation

Lower-extremity amputation without prosthetic (BKA, AKA) -Orthopedic or neurologic condition that would preclude walking or tensing/releasing of muscles-

Trial design

Treatments tested in this trial

  • Fight Fatigue
  • Attention Control

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Illinois at Chicago

Lead sponsor

National Center for Complementary and Integrative Health (NCCIH)

Collaborator